Cannabis company receives approval for COVID-19 dose finding study
MGC Pharma has received approval for a dose finding study for its proprietary treatment for the effects of COVID-19.
MGC Pharma has received approval for a dose finding study for its proprietary treatment for the effects of COVID-19.
Harbour Access has been appointed as North American investor relations advisor to provide support for the listing.
US cannabis investment company Thought Leaders has acquired UK CBD brand mellow.
CimetrAâ„¢ has been proven through clinical trials to help symptoms of severe Covid-19
Yooma Wellness has acquired the Japanese Wellness brand Vertex Co. for US$12,000,000. Vertically integrated global wellness platform, Yooma Wellness, which
Increasing demand for CBD-infused pet food is contributing to market growth.
MGC Pharmaceuticals has received a Free Trade Certificate in Germany for its product ArtemiC which has shown successful results in
The move sees GenCanna continue to expand across global markets
New analysis shows that the CBD market will see massive growth in the coming years as the compound’s use gains popularity for issues such as anxiety and sleep.
Oxford Cannabinoid Technologies has applied to be admitted to the OTC QB Market in the United States. Oxford Cannabinoid Technologies
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.